Cite

    Mosna, F. et al. (n.d.). Complex karyotype, older age, and reduced first‐line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long‐term follow‐up. American journal of hematology. 90 (6), pp. 515-523. [Online].